Stockscreener 앱 받기
15.46
1.72%
-0.27
시장 영업 전:
15.46
Immunovant Inc 주식(IMVT)의 최신 뉴스
Candlestick Reversal Detected on Immunovant Inc.’s ChartReal Time Alerts Based on AI Prediction Triggered - metal.it
Is Immunovant Inc. a growth stock or a value stockStrong return on investment - Jammu Links News
How does Immunovant Inc. compare to its industry peersAchieve rapid portfolio appreciation today - Jammu Links News
What are the technical indicators suggesting about Immunovant Inc.Massive wealth growth - Jammu Links News
Is Immunovant Inc. a good long term investmentFastest-growing stock picks - Jammu Links News
Should I hold or sell Immunovant Inc. stock in 2025Sky-high return potential - Jammu Links News
When is Immunovant Inc. stock expected to show significant growthTriple-digit growth rates - Jammu Links News
How volatile is Immunovant Inc. stock compared to the marketUnmatched market gains - Jammu Links News
What drives Immunovant Inc. stock priceCapitalize on market opportunities with confidence - Jammu Links News
What institutional investors are buying Immunovant Inc. stockOutperformance with explosive growth - Jammu Links News
Is it the right time to buy Immunovant Inc. stockFree Stock Movement Tracking - Jammu Links News
What catalysts could drive Immunovant Inc. stock higher in 2025Breakthrough wealth creation - Jammu Links News
Is Immunovant Inc. stock overvalued or undervaluedBuild a portfolio that outperforms the market - Jammu Links News
What are analysts’ price targets for Immunovant Inc. in the next 12 monthsOutstanding growth strategies - Jammu Links News
How does Immunovant Inc. generate profit in a changing economyFree Capital Growth Strategies - Jammu Links News
What analysts say about Immunovant Inc. stockCapitalize on market momentum for big wins - Jammu Links News
How many analysts rate Immunovant Inc. as a “Buy”Get daily updates on top-performing stocks - Jammu Links News
Why is Immunovant Inc. stock attracting strong analyst attentionMaximize gains with expert trading strategies - Jammu Links News
LifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PT - MSN
What makes Immunovant Inc. stock price move sharplyBest Dividend Outlook For Consistent Profits - Jammu Links News
Immunovant appoints Eric Venker as CEO with new compensation agreement By Investing.com - Investing.com Canada
Immunovant Appoints Eric Venker as New CEO - TipRanks
Momentum Screeners Rank Immunovant Inc. in Top 5 TodayReversal Alert Based on RSI Indicator Confirmed - metal.it
Immunovant Inc. Hits Oversold Level on RSI IndicatorProfit Focused Stock Screener Results Released - metal.it
Immunovant Inc. stock volume spike explainedFree Fast Return Equity Trade Forecast - Newser
Immunovant Inc. stock daily chart insightsFree Risk Controlled Short Term Trade Plans - Newser
Can momentum traders help lift Immunovant Inc.Chart Driven Entry Timing for Swing Trades - Newser
Immunovant Inc. Company Revenue and Profit Trends: A Deep DiveFree Real-Time Stock Data - metal.it
What is the dividend policy of Immunovant Inc. stockInvest smarter with real-time trading signals - jammulinksnews.com
Immunovant (IMVT) Gets a Buy from Cantor Fitzgerald - The Globe and Mail
Bank of New York Mellon Corp Reduces Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Cantor Fitzgerald's Schmidt FCA Reiterates Buy Rating on Immunovant with a $37.22 Average Price Target. - AInvest
Immunovant Executives Sell Shares to Cover Tax Obligations - TradingView
Can Immunovant Inc. stock recover from recent declineHigh-profit stock alerts - jammulinksnews.com
Immunovant Plunges 7.64%, Is This a Buying Opportunity or a Warning Sign? - AInvest
Immunovant CMO and CTO sell shares at $18.15 on July 23, 2025. - AInvest
0.24%
3.39%
자본화:
|
볼륨(24시간):